Results 321 to 330 of about 1,140,223 (331)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 2003
Renal cell carcinoma (RCC) continues to present a diagnostic and therapeutic challenge. The increased use of abdominal imaging studies does not appear to completely account for the rising incidence of RCC. Alcohol consumption has been found to be a possible protective factor among women in a recent study, but among women with children, RCC risk may ...
Young E, Whang, Paul A, Godley
openaire +2 more sources
Renal cell carcinoma (RCC) continues to present a diagnostic and therapeutic challenge. The increased use of abdominal imaging studies does not appear to completely account for the rising incidence of RCC. Alcohol consumption has been found to be a possible protective factor among women in a recent study, but among women with children, RCC risk may ...
Young E, Whang, Paul A, Godley
openaire +2 more sources
The Lancet
The landscape of the management of renal cell carcinoma has evolved substantially in the last decade, leading to improved survival in localised and advanced disease. We review the epidemiology, pathology, and diagnosis of renal cell carcinoma and discuss the evidence for current management strategies from localised to metastatic disease.
Matthew, Young+7 more
openaire +2 more sources
The landscape of the management of renal cell carcinoma has evolved substantially in the last decade, leading to improved survival in localised and advanced disease. We review the epidemiology, pathology, and diagnosis of renal cell carcinoma and discuss the evidence for current management strategies from localised to metastatic disease.
Matthew, Young+7 more
openaire +2 more sources
Radiotherapy for renal-cell carcinoma
The Lancet Oncology, 2014Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be wrong. If given in a few (even single) fractions, but at a high fraction dose, stereotactic body radiotherapy becomes increasingly important in the management of renal-cell carcinoma, both in primary settings and in treatment of oligometastatic disease.
De Meerleer, Gert+11 more
openaire +3 more sources
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma
Nature reviews. Urology, 2022M. Rosellini+5 more
semanticscholar +1 more source
Epidemiology of Renal Cell Carcinoma: 2022 Update.
European Urology, 2022L. Bukavina+15 more
semanticscholar +1 more source
Bulletin of Tufts New England Medical Center, 1956
M. Thurnher+7 more
semanticscholar +1 more source
M. Thurnher+7 more
semanticscholar +1 more source
Targeting the HIF2–VEGF axis in renal cell carcinoma
Nature Network Boston, 2020T. Choueiri, W. Kaelin
semanticscholar +1 more source
The immunology of renal cell carcinoma
Nature Reviews Nephrology, 2020C. Diaz-Montero, B. Rini, J. Finke
semanticscholar +1 more source
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications
Nature reviews. Urology, 2019W. M. Linehan, C. Ricketts
semanticscholar +1 more source